FORUM Pharmaceuticals is currently conducting clinical trials and focusing its research on the many unmet needs surrounding Alzheimer’s disease and schizophrenia. Our goal is to significantly improve the quality of life for patients with these disorders and work towards advances in therapies that will bring an end to serious brain diseases.
This section includes
- More information about unmet needs in the treatment of schizophrenia and Alzheimer’s disease
- Our programs and ongoing clinical trials